AXDX Key Statistics, Chart & Performance
The current stock price of AXDX is 0.034 USD. In the past month the price decreased by -93.7%. In the past year, price decreased by -96.15%.
AXDX Technical Analysis
AXDX Financial Highlights
Over the last trailing twelve months AXDX reported a non-GAAP Earnings per Share(EPS) of -2.38. The EPS increased by 35.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -175.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AXDX Forecast & Estimates
For the next year, analysts expect an EPS growth of 14.29% and a revenue growth 3.44% for AXDX
AXDX Ownership
AXDX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.4 | 211.72B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.14 | 189.66B | ||
| SYK | STRYKER CORP | 27.62 | 139.12B | ||
| BSX | BOSTON SCIENTIFIC CORP | 29.85 | 130.56B | ||
| BDX | BECTON DICKINSON AND CO | 14.36 | 59.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.73 | 57.12B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.82 | 48.95B | ||
| RMD | RESMED INC | 26.02 | 37.60B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.81 | 37.24B | ||
| DXCM | DEXCOM INC | 37.39 | 27.12B | ||
| PODD | INSULET CORP | 62.95 | 20.24B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.79 | 17.30B |
Related stock screener links
About AXDX
Company Profile
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Denver, Colorado and currently employs 107 full-time employees. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company Info
ACCELERATE DIAGNOSTICS INC
3950 S Country Club Rd Ste 470 Bldg 3-307
Denver COLORADO 85714 US
CEO: Jack Phillips
Employees: 107
Phone: 13038638088
ACCELERATE DIAGNOSTICS INC / AXDX FAQ
Can you describe the business of ACCELERATE DIAGNOSTICS INC?
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. The company is headquartered in Denver, Colorado and currently employs 107 full-time employees. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Can you provide the latest stock price for ACCELERATE DIAGNOSTICS INC?
The current stock price of AXDX is 0.034 USD. The price decreased by -61.36% in the last trading session.
What is the dividend status of ACCELERATE DIAGNOSTICS INC?
AXDX does not pay a dividend.
How is the ChartMill rating for ACCELERATE DIAGNOSTICS INC?
AXDX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
How is the valuation of ACCELERATE DIAGNOSTICS INC (AXDX) based on its PE ratio?
ACCELERATE DIAGNOSTICS INC (AXDX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.38).
What is the employee count for AXDX stock?
ACCELERATE DIAGNOSTICS INC (AXDX) currently has 107 employees.
Who owns ACCELERATE DIAGNOSTICS INC?
You can find the ownership structure of ACCELERATE DIAGNOSTICS INC (AXDX) on the Ownership tab.